Controlled inpatient study of tienilic acid in treatment of gout and hypertension
Under inpatient controlled conditions 4 patients with gout and hypertension were treated with varying doses of tienilic acid, a new uricosuric diuretic. Plasma urate levels were reduced by an average of 50% in association with significantly increased urinary urate excretion. A twice-daily regimen wa...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 39; no. 4; pp. 367 - 372 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group Ltd and European League Against Rheumatism
01.08.1980
BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Under inpatient controlled conditions 4 patients with gout and hypertension were treated with varying doses of tienilic acid, a new uricosuric diuretic. Plasma urate levels were reduced by an average of 50% in association with significantly increased urinary urate excretion. A twice-daily regimen was considerably more effective than a single morning dosage in reduction of plasma urate, though both regimens were equally effective in antihypertensive potency. The single daily regimen produced greater diurnal fluctuations in plasma urate and was more frequently associated with the development of acute gout attacks. |
---|---|
Bibliography: | istex:53E36288B06DC327770271611ADE89D6F5EEF77A ark:/67375/NVC-V7GWHBM5-4 PMID:7436563 local:annrheumdis;39/4/367 href:annrheumdis-39-367.pdf ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/ard.39.4.367 |